Stay updated on Moderna Press Releases

Sign up to get notified when there's something new on the Moderna Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Moderna Press Releases page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    The pricing has decreased from $27.61 to $26.12, and stock availability has significantly reduced from 16.28M to 6.61M.
    Difference
    3%
    Check dated 2025-08-09T15:36:43.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the reporting of Moderna's second quarter 2025 financial results and the confirmation of the validity of its patent against Pfizer/BioNTech. Additionally, the pricing of a product has decreased from $34.15 to $27.61.
    Difference
    100%
    Check dated 2025-08-02T14:23:17.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The page has updated the pricing of a product from $31.26 to $34.15 and revised stock availability from 7.82M to 5.37M. Additionally, it includes a new positive opinion from the EMA regarding Moderna's COVID-19 vaccine targeting a specific variant.
    Difference
    19%
    Check dated 2025-07-26T12:20:07.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    Moderna has received U.S. FDA approval for its RSV vaccine, mRESVIA, for adults aged 18-59 at increased risk for RSV disease, and has also received full U.S. FDA approval for its COVID-19 vaccine, Spikevax, for children aged 6 months through 11 years at increased risk for COVID-19 disease.
    Difference
    76%
    Check dated 2025-07-19T10:57:46.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    The page now displays 27 news items from 2025, including significant updates about Moderna's FDA approval for its COVID-19 vaccine for children and an upcoming financial report.
    Difference
    11%
    Check dated 2025-07-12T04:53:13.000Z thumbnail image
  10. Check
    74 days ago
    Change Detected
    Summary
    The page now displays 25 news items from the year 2025, up from 24, and includes a new announcement from Moderna regarding positive Phase 3 results for a seasonal influenza vaccine dated June 30, 2025.
    Difference
    4%
    Check dated 2025-07-05T02:22:59.000Z thumbnail image

Stay in the know with updates to Moderna Press Releases

Enter your email address, and we'll notify you when there's something new on the Moderna Press Releases page.